Shin-Etsu Chemical (TSE:4063) Stock EPS Rebound Tests Margin Compression Narrative In Q1 2027

Shin-Etsu Chemical (TSE:4063) has opened Q1 2027 with revenue of ¥662.4 billion and basic EPS of ¥70.39, setting the tone for how investors assess both growth and profitability this year. The company has seen quarterly revenue move from ¥628.5 billion in Q1 2026 to ¥662.4 billion in Q1 2027, while basic EPS shifted from ¥66.47 to ¥70.39 over the same period. This gives investors a clear view of how the top line and per share earnings are tracking into the new fiscal year. With trailing net profit margins softer than a year ago, this set of results puts the focus firmly on whether Shin-Etsu Chemical can sustain earnings momentum while stabilising profitability.

See our full analysis for Shin-Etsu Chemical.

With the headline numbers on the table, the next step is to line them up against the most common narratives around Shin-Etsu Chemical to see which stories hold up and which start to look overstretched.

Curious how numbers become stories that shape markets? Explore Community Narratives

Margins Ease Back To 18.4%

• Over the last 12 months, Shin-Etsu Chemical has a net profit margin of 18.4%, compared with 20.9% a year earlier, on trailing revenue of ¥2,607.8b and net income of ¥478.9b.
• Bears point to this margin drift as a concern, yet the figures show a more balanced picture:
  • The trailing basic EPS of ¥256.50 sits against net income of ¥478.9b, which still reflects sizeable profitability even with the margin step down from 20.9%.
  • Critics highlight the recent margin movement, but the company has generated net income between ¥474.5b and ¥516.4b over the last five trailing periods, so profitability has remained in a relatively tight band.

Q1 EPS Rebounds From Q4 Dip

• Basic EPS in Q1 2027 was ¥70.39 compared with ¥48.40 in Q4 2026 and ¥66.47 in Q1 2026, while net income moved from ¥90,139m in Q4 2026 to ¥130,829m in Q1 2027.
• Supporters of a more bullish view see this pattern as backing the idea of resilient earnings power, but the quarterly swings keep the debate alive:
  • What stands out is that Q1 2027 EPS of ¥70.39 is close to the Q2 2026 high of ¥70.16, suggesting the recent low point was the ¥48.40 in Q4 rather than a new trend.
  • At the same time, trailing EPS of ¥256.50 is slightly below the ¥263.73 recorded a year earlier, so the latest quarter strength sits against a year where overall earnings growth was softer.

For investors trying to connect this EPS rebound with the broader story around growth, risk, and valuation, it helps to see how other market participants are framing Shin-Etsu Chemical right now, and how that might differ from your own take, before reacting to a single quarter of numbers 📊 Read the what the Community is saying about Shin-Etsu Chemical..

Premium 26.3x P/E, Yet Below DCF Value

• Shin-Etsu Chemical trades on a P/E of 26.3x versus peers at 20.8x and the Japan chemicals industry at 13.5x, while the current share price of ¥6,702 sits below a DCF fair value estimate of ¥8,142.02.
• What is interesting for bullish investors is how these valuation signals pull in different directions:
  • The stock sits about 19.5% below the DCF fair value of ¥8,142.02 and around 20.3% below the analyst price target of ¥8,074.71, which aligns with views that there could be upside from ¥6,702.
  • On the other hand, the 26.3x P/E premium over both peers and the wider chemicals industry means part of the share price already reflects stronger forecast growth of about 10.5% a year for earnings and 6.8% a year for revenue.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Shin-Etsu Chemical's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Mixed signals around Shin-Etsu Chemical's margins, earnings, and valuation can feel unclear, so it is worth checking the underlying data yourself and weighing the trade off between the concerns and the potential upside. To see the balance of risks and rewards investors are focused on, start with the 3 key rewards and 1 important warning sign.

See What Else Is Out There

Shin-Etsu Chemical shows softer net margins and trailing EPS compared with a year earlier, while still trading on a premium 26.3x P/E.

If this mix of easing profitability and a higher earnings multiple leaves you cautious, quickly compare it with companies filtered through the 52 resilient stocks with low risk scores to focus on stocks with more resilient risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com